| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 9e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.075 | 0.1 |